Quotes 5-day view Delayed Nasdaq
62 265 Volume
Estimated financial data (e) (USD)
Net income 2022
Net Debt 2022
P/E ratio 2022
Net income 2023
Net Debt 2023
P/E ratio 2023
Capi. / Sales 2022
Capi. / Sales 2023
Nbr of Employees
Quoin Pharmaceuticals Ltd, former Cellect Biotechnology Ltd, is an Israel-based specialty pharmaceutical company, focused on developing and commercializing therapeutic products that treat rare and orphan diseases. The Companyâ€™s first lead product is QRX003, a once daily, topical lotion comprised of a broad-spectrum serine protease inhibitor, formulated with the proprietary Invisicare technology, to treat Netherton...
Ratings of Quoin Pharmaceuticals, Ltd.
All news about QUOIN PHARMACEUTICALS, LTD.
08:31a Quoin Pharmaceuticals Enters Exclusive Research Agreement for Scleroderma Treatment wit..
05/06 Ladenburg Thalmann Starts Quoin Pharmaceuticals at Buy With $2 Price Target
04/25 Quoin Says FDA Clears Investigational New Drug Application for Netherton Syndrome Candi..
04/25 Quoin Pharmaceuticals Announces FDA Clearance of IND for its Lead Asset, QRX003, for Ne..
04/25 Quoin Pharmaceuticals, Ltd. Announces FDA Clearance of IND for its Lead Asset, QRX003, ..
04/14 Quoin Pharmaceuticals, Ltd. Reports Earnings Results for the Full Year Ended December 3..
03/15 Quoin Pharmaceuticals Announces Submission of IND for its Lead Asset, QRX003, for Nethe..
03/15 Quoin Pharmaceuticals Announces Submission of IND for Its Lead Asset, QRX003, for Nethe..
03/10 Quoin Pharmaceuticals Submits Scientific Advice Briefing Document to EMA for its Lead A..
03/08 QUOIN PHARMACEUTICALS : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON APR..
03/01 Quoin Pharma Extends Distribution Deal With Partner ER-Kim for Skin Disease Drug Candid..
03/01 Quoin Pharmaceuticals Extends Exclusive Distribution Agreement with ER-Kim for its Lead..
03/01 Quoin Pharmaceuticals, Inc. Extends Exclusive Distribution Agreement with ER-Kim for it..
02/17 Quoin Pharmaceuticals Signs Exclusive Distribution Agreement with Neopharm for its Lead..
02/17 Quoin Pharmaceuticals Signs Exclusive Distribution Agreement with Neopharm for Its Lead..
News in other languages on QUOIN PHARMACEUTICALS, LTD.
Analyst Recommendations on QUOIN PHARMACEUTICALS, LTD.
Chart QUOIN PHARMACEUTICALS, LTD.
Technical analysis trends QUOIN PHARMACEUTICALS, LTD.
Short Term Mid-Term Long Term Trends Bearish Bearish Neutral
Number of Analysts
Last Close Price
Average target price
Spread / Average Target